A detailed history of Jane Street Group, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 50,966 shares of AXNX stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,966
Previous 20,946 143.32%
Holding current value
$3.5 Million
Previous $1.44 Million 137.26%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $2 Million - $2.09 Million
30,020 Added 143.32%
50,966 $3.43 Million
Q1 2024

May 15, 2024

SELL
$56.67 - $69.36 $873,624 - $1.07 Million
-15,416 Reduced 42.4%
20,946 $1.44 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $301,069 - $388,683
6,097 Added 20.15%
36,362 $2.26 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $448,314 - $576,154
9,217 Added 43.79%
30,265 $1.7 Million
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $818,709 - $1.03 Million
-17,060 Reduced 44.77%
21,048 $1.06 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $1.29 Million - $1.65 Million
24,545 Added 180.97%
38,108 $2.08 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $407,986 - $524,710
-6,850 Reduced 33.56%
13,563 $848,000
Q3 2022

Nov 14, 2022

SELL
$57.96 - $78.12 $2.72 Million - $3.67 Million
-46,999 Reduced 69.72%
20,413 $1.44 Million
Q2 2022

Aug 16, 2022

BUY
$39.5 - $64.42 $1.39 Million - $2.27 Million
35,209 Added 109.33%
67,412 $3.82 Million
Q1 2022

May 17, 2022

BUY
$43.74 - $62.76 $1.21 Million - $1.73 Million
27,578 Added 596.28%
32,203 $2.02 Million
Q4 2021

Feb 15, 2022

SELL
$50.01 - $73.35 $639,077 - $937,339
-12,779 Reduced 73.43%
4,625 $259,000
Q3 2021

Nov 16, 2021

BUY
$59.21 - $78.66 $254,958 - $338,709
4,306 Added 32.88%
17,404 $1.13 Million
Q2 2021

Aug 16, 2021

SELL
$51.39 - $66.9 $269,078 - $350,288
-5,236 Reduced 28.56%
13,098 $831,000
Q1 2021

May 18, 2021

BUY
$49.14 - $59.89 $404,471 - $492,954
8,231 Added 81.47%
18,334 $1.1 Million
Q4 2020

Feb 17, 2021

BUY
$42.19 - $51.5 $126,105 - $153,933
2,989 Added 42.02%
10,103 $504,000
Q3 2020

Nov 17, 2020

BUY
$35.33 - $51.04 $39,145 - $56,552
1,108 Added 18.45%
7,114 $363,000
Q2 2020

Aug 17, 2020

SELL
$22.91 - $39.83 $42,841 - $74,482
-1,870 Reduced 23.74%
6,006 $211,000
Q1 2020

May 15, 2020

BUY
$16.44 - $37.73 $129,481 - $297,161
7,876 New
7,876 $200,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.38B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.